Intraductal Papillary Mucinous Neoplasm of Pancreas
6 clinical trials · Condition
◉ Watch Intraductal Papillary Mucinous Neoplasm of Pancreas
| Record | Firm | Date |
|---|---|---|
| Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07709052) | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2026-09-01 |
| Impact of GLP-1 Receptor Agonists on Patients With IPMN (NCT07014709) | Hôpital Fribourgeois | 2025-05-31 |
| Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts (NCT06162468) | University of Auckland, New Zealand | 2025-05-31 |
| Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data (NCT07463872) | Huazhong University of Science and Technology | 2025-01-01 |
| Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia. (NCT05914077) | Fundacion Clinic per a la Recerca Biomédica | 2023-09-13 |
| Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas (NCT06706700) | IRCCS San Raffaele | 2020-07-13 |
Track Intraductal Papillary Mucinous Neoplasm of Pancreas automatically
Every clearance here is in the API, with alerts when new ones post.